Immunogenicity of Adjuvanted or Non-adjuvanted H5N1 Booster Vaccine in Adults Primed to A/VN/1194/04

This study has been completed.
Sponsor:
Collaborators:
Medical Research Council
Novartis
Health Protection Agency, United Kingdom
National Institute of Biological Standards and Control
Information provided by (Responsible Party):
University Hospitals, Leicester
ClinicalTrials.gov Identifier:
NCT00814385
First received: December 23, 2008
Last updated: June 2, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)